Clinical Trial Update: A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

View source ↗

Summary

Clinical trial update describing the use of aflibercept in routine medical practice for Japanese participants with neovascular age-related macular degeneration …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME) | Status: ACTIVE_NOT_RECRUITING